We are live on ! Find out more
PCA

Private Capital Advisors Portfolio holdings

AUM $1.15B Turnover 18.82%
1-Year Est. Return 43.46%
This Fund
S&P 500
This Quarter Est. Return
+1.58%
1 Year Est. Return
+43.46%
3 Year Est. Return
+131.91%
5 Year Est. Return
+229.29%
10 Year Est. Return
+757.55%
AUM
$224M
AUM Growth
-$7.34M
Cap. Flow
-$6.76M
Cap. Flow %
-3.02%
Top 10 Hldgs %
32.72%
Holding
117
New
10
Increased
8
Reduced
37
Closed
12
Avg Time Held
2 years
Top 10 Avg Time Held
0.8 years
Top 20 Avg Time Held
1.3 years

Top Buys

Rank Stock Value
1
RTN
Raytheon Company
RTN
+$6.31M
2
ADBE icon
Adobe
ADBE
+$3.36M
3
SYK icon
Stryker
SYK
+$3.14M
4
JPM icon
JPMorgan Chase
JPM
+$2.44M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.91M

Sector Composition

Rank Sector Weight
1 Communication Services 25.3%
2 Healthcare 20.7%
3 Energy 14.37%
4 Industrials 12.84%
5 Technology 8.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
JNJ icon
51
Johnson & Johnson
JNJ
$616B
$1.18M 0.52%
10,855
– –
2013 Q2
11 quarters
KKR icon
52
KKR & Co
KKR
$77.4B
$1.15M 0.51%
78,015
-785
-1% -$10.7K
2014 Q2
7 quarters
LBRDK icon
53
DELISTED
Liberty Broadband Class C
LBRDK
$1.1M 0.49%
19,016
-66
-0.3% -$3.32K
2014 Q4
5 quarters
AMZN icon
54
Amazon
AMZN
$2.7T
$1.09M 0.49%
+36,900
New +$1.05M
2016 Q1
0 quarters
CHTR icon
55
Charter Communications
CHTR
$12.6B
$1.05M 0.47%
5,200
– –
2013 Q2
11 quarters
GILD icon
56
Gilead Sciences
GILD
$194B
$1.03M 0.46%
11,194
– –
2013 Q2
11 quarters
WRK icon
57
DELISTED
WestRock Company
WRK
$971K 0.43%
27,623
– –
2015 Q3
2 quarters
CVS icon
58
CVS Health
CVS
$118B
$877K 0.39%
8,450
– –
2013 Q2
11 quarters
RH icon
59
RH
RH
$2.14B
$873K 0.39%
20,830
– –
2015 Q2
3 quarters
KO icon
60
Coca-Cola
KO
$404B
$835K 0.37%
18,000
– –
2013 Q2
11 quarters
MSFT icon
61
Microsoft
MSFT
$3.93T
$822K 0.37%
14,878
+3
+0% +$157
2013 Q2
11 quarters
EQT icon
62
EQT Corp
EQT
$34B
$760K 0.34%
20,767
– –
2015 Q2
3 quarters
QQQ icon
63
Invesco QQQ Trust
QQQ
$475B
$731K 0.33%
6,690
– –
2013 Q2
11 quarters
UAN icon
64
CVR Partners
UAN
$1.34B
$727K 0.32%
8,696
-60
-0.7% -$3.96K
2013 Q2
11 quarters
BALL icon
65
Ball Corp
BALL
$16.7B
$722K 0.32%
20,260
– –
2013 Q2
11 quarters
AEP icon
66
American Electric Power
AEP
$69.2B
$716K 0.32%
10,790
– –
2013 Q2
11 quarters
TRGP icon
67
Targa Resources
TRGP
$63.2B
$687K 0.31%
+23,014
New +$549K
2016 Q1
0 quarters
INTU icon
68
Intuit
INTU
$86.9B
$640K 0.29%
6,150
– –
2013 Q2
11 quarters
FISV icon
69
Fiserv Inc
FISV
$25.3B
$626K 0.28%
12,200
– –
2013 Q2
11 quarters
ORCL icon
70
Oracle
ORCL
$389B
$595K 0.27%
14,555
– –
2013 Q2
11 quarters
LBRDA icon
71
DELISTED
Liberty Broadband Class A
LBRDA
$476K 0.21%
8,182
-36
-0.4% -$1.81K
2014 Q4
5 quarters
DISH
72
DELISTED
DISH Network Corp.
DISH
$472K 0.21%
10,200
– –
2013 Q2
11 quarters
BMY icon
73
Bristol-Myers Squibb
BMY
$122B
$453K 0.2%
7,097
– –
2013 Q2
11 quarters
MRK icon
74
Merck
MRK
$360B
$450K 0.2%
8,908
– –
2013 Q2
11 quarters
TROW icon
75
T. Rowe Price
TROW
$21.5B
$436K 0.19%
5,930
– –
2013 Q2
11 quarters

Similar funds

Private Capital Advisors's Q1 2016 Portfolio in Review

As of Q1 2016, Private Capital Advisors held 117 positions worth $224M, down 3.2% from $232M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Private Capital Advisors withdrew a net $6.76M in Q1 2016, closing 12 positions and reducing 37 holdings. Its most notable exit was Tvardi Therapeutics, an estimated $4.16M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Energy.

Against the trend, Private Capital Advisors opened a new position in Raytheon Company worth $6.28M.

  • Private Capital Advisors's largest Q1 2016 buy was Raytheon Company: 51,240 shares worth $6.28M.
  • Private Capital Advisors added most to Alphabet (Google) Class A in Q1 2016, an estimated $1.91M increase.
  • Private Capital Advisors's biggest Q1 2016 reduction was 3M, cutting an estimated $4.07M.
  • Private Capital Advisors fully exited Tvardi Therapeutics in Q1 2016, selling an estimated $4.16M.
  • Private Capital Advisors's ten largest holdings make up 33% of its $224M portfolio in Q1 2016.
  • Private Capital Advisors opened 10 new positions and closed 12 in Q1 2016.
  • Private Capital Advisors's portfolio value fell 3.2% quarter-over-quarter to $224M.

Based on Private Capital Advisors's 13F filing for Q1 2016, filed 26 Apr 2016.